DelveInsight's 'Multiple Sclerosis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline multiple ...

Theravance Biopharma ( (TBPH) ) has released its Q3 earnings. Here is a breakdown of the information Theravance Biopharma presented to its ...

DUBLIN, Nov. 12, 2024 /PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial and operational results for the third quarter of 2024 ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

CNW/ - GSK announced today that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or ...

GSK has licensed a small molecule for Parkinson's and is teaming up on additional targets for the disease and another ...

Healthcare Analysts discuss the recently-held AASLD Meeting (relevant companies ABUS HOOK BRNS VIR GSK (GSK) ALGS GILD) and catch-up on Chronic ...

RSV vaccine sales from GSK and Pfizer have dropped significantly ... rising interest expenses, and a weaker biopharma funding environment. Vandana Singh IQVIA Up 3.4% Since Last Earnings Report ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

The "CC Chemokine Receptor Type 5 Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The CC ...